With $30 Million Gift, UAB Says Cancer Research is the Future of Birmingham
Eva Carter is in her 70s and for most of her life, she says she never had any health problems. That changed five years ago.
“I was bulldozed with, ‘You have the most aggressive type of breast cancer,’” Carter says.
She received a diagnosis of triple negative breast cancer. Her doctors at UAB recommended a clinical trial. She would test out a new drug therapy not yet approved by the FDA. Carter agreed to give it a try.
“I was fighting for my life and anything that I could do to enhance my chances of living longer, I was going to do it,” she says. “If it didn’t work, it didn’t work.”
Clinical trials are experiments, research studies to test the effectiveness of a new drug. The cancer center’s director, Dr. Michael Birrer, says that should not deter patients. He says today, more than ever, these studies are carefully done and represent the future of oncology research. For that reason, the center wants to do more of them, with plans to eventually triple its number of clinical trials. Birrer says they are especially interested in increasing the amount of early phase trials, when drugs are first tested on humans.
“It’s no longer, ‘Hey here’s a phase 1 and your chance of responding is very low,’” Birrer says. “We now have success rates in these trials that’s high, and so it’s much more relevant to patients.”
There is also an economic incentive. Birrer says the recent $30 million gift from O’Neal Industries will help fund physician-led research, hire clinical staff and increase patient participation. This lays the groundwork to attract small pharmaceutical, or biotech companies. Birrer says these groups are changing the face of research. They are nimble and hungry to develop new therapies. With enough investment, he says Birmingham could develop a biotech park in the future.
“Companies will come and say, ‘We have a new agent, looks good. Can you open this trial up and get the job done?’” Birrer says. “If we can do that fast enough and we do that often enough, I think they’ll open up an office down here or they might even bring their headquarters down here.”
For patients, that means access to the newest therapies, and they typically do not have to pay for treatment. But participating in a clinical trial is not easy. They often require daily or weekly visits to the cancer center and following a diet or exercise plan. Additionally, there are the side effects. For Eva Carter, it was worth it.
“My oncologist called me at 8’oclock one night, and I said, ‘Oh lord, does this mean I’m dead?’” Carter says, “and he called and said, ‘I just saw your MRI and we can’t even measure the tumor now. We can’t even measure it.’”
Carter says she understands why some people hesitate to participate in trials. Specifically within the African-American community, she says there is a legacy of distrust, marked by the Tuskegee study, when African-American men were unknowingly left untreated for syphilis for decades. Carter says that is why it is especially important patients have doctors they can trust, who explain the clinical trial and any risks associated with it. She also says patients should do their own research.
“I am so happy that the lord gave me the wisdom and the courage and the internet to look up the information on a clinical trial,” Carter says.
This year, more than 500 people have participated in a clinical trial at the O’Neal Comprehensive Cancer Center at UAB. Next year, the goal is to enroll about 700. The growth is expected to drive economic development, but more importantly, it will offer more patients, more options to fight cancer.
How Alabama Power kept bills up and opposition out to become one of the most powerful utilities in the country
In one of the poorest states in America, the local utility earns massive profits producing dirty energy with almost no pushback from state regulators.
No more Elmo? APT could cut ties with PBS
The board that oversees Alabama Public Television is considering disaffiliating from PBS, ending a 55-year relationship.
Nonprofit erases millions in medical debt across Gulf South, says it’s ‘Band-Aid’ for real issue
Undue Medical Debt has paid off more than $299 million in medical debts in Alabama. Now, the nonprofit warns that the issue could soon get worse.
Roy Wood Jr. on his father, his son and his new book
Actor, comedian and writer Roy Wood Jr. is out with a new book -- "The Man of Many Fathers: Life Lessons Disguised as a Memoir." He writes about his experience growing up in Birmingham, losing his dad as a teenager and all the lessons he learned from various father figures throughout his career.
Auburn fires coach Hugh Freeze following 12th loss in his last 15 SEC games
The 56-year-old Freeze failed to fix Auburn’s offensive issues in three years on the Plains, scoring 24 or fewer points in 17 of his 22 league games. He also ended up on the wrong end of too many close matchups, including twice this season thanks partly to questionable calls.
In a ‘disheartening’ era, the nation’s former top mining regulator speaks out
Joe Pizarchik, who led the federal Office of Surface Mining Reclamation and Enforcement from 2009 to 2017, says Alabama’s move in the wake of a fatal 2024 home explosion increases risks to residents living atop “gassy” coal mines.
